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Introduction
Alkaptonuria is a rare recessive autosomal metabolic disease caused by absence of the enzyme homogentisic oxidase. This enzyme is responsible for degradation of homogentisic acid, which is an intermediate product from metabolism of the amino acids tyrosine and phenylalanine. If this enzyme is defective, this leads to accumulation of homogentisic acid in tissues and blood.
The incidence of alkaptonuria is less than one in one million. 1 Over time, the deposits of homogentisic acid accumulate in the tissues and present as a dark pigmentation. This condition is called ochronosis and it may affect not only the musculoskeletal system but also the cardiovascular and genitourinary systems, the sclera and the skin. 2, 3 Most of the symptoms of alkaptonuria are only observed starting in the fourth or fifth decade of life, 4 except for the appearance of dark urine, which is detected during childhood, resulting from excretion and oxidation of homogentisic acid.
Alkaptonuria causes progressive ochronotic arthropathy of the major joints that are subject to weight-bearing. The knee is the joint that is most affected, followed by the hip. [4] [5] [6] The treatment for the disease is symptomatic and total arthroplasty is the preferred treatment in severe cases of osteoarthrosis. 7, 8 
Clinical case
The patient was a 67-year-old man whose diagnosis of alkaptonuria had been made at the age of 40 years. The first signs of the disease were darkening of the urine and appearance of dark pigments in the sclera, ears and first interdigital crease of the left hand ( Fig. 1A-D ). There were no other relevant antecedents or any family history of the disease.
At the age of 60 years, the patient underwent a surgical intervention to extract a bladder stone of large dimensions (Fig. 2) .
Joint complaints arose some years later and initially affected the left hip, followed by the left knee and lastly the right knee.
The patient was referred for an orthopedics consultation and the first surgical intervention was total arthroplasty of the left hip, performed five years before the present case ( Fig. 3A and B).
Twelve months before the present case, the patient underwent total arthroplasty of the left knee ( Fig. 4A-C) . Both of these surgical procedures were performed at another hospital institution. So far, there have not been any mentions of postoperative complications.
At the consultation of the present case, the patient presented complaints of pain in his right knee, with a varus knee and radiologically observed three-compartment gonarthrosis of Ahlbäck grade IV ( Fig. 4A and B) .
The patient underwent total arthroplasty of the right knee ( Fig. 5A and B) at our hospital. The complaints of pain improved immediately after the operation.
After six months of follow-up, the patient is now asymptomatic and able to walk without gait supports. His mobility is from 0 • to 110 • in the right knee and 0 • to 120 • in the left knee. He continues to be followed up as an outpatient.
Discussion
Alkaptonuria was first described in 1584, in children with dark urine.
At the end of the 1990s, it was observed that the gene for this pathological condition was present at the locus 3q21-23. 9 Ochronosis consists of deposition of pigments from homogentisic acid in all types of connective tissue and particularly in cartilage. It mainly affects the musculoskeletal system, but can also affect the cardiovascular and genitourinary systems, the sclera and the skin. 2, 3 The first clinical manifestation of alkaptonuria is the appearance of dark urine. 10 Other alterations that are often neglected include changes to the color of the sclera and ears. These signs could also be identified in our patient.
Ochronotic arthropathy fundamentally affects individuals from the age of 40 years onwards, as seen in the case presented here. The pain complaints affect the major joints and especially the knees, followed by the hips, shoulders, spine and even the ribs. 11 In our case, the first joint to be affected was the left hip.
The pigmentation also affects the tendons and ligaments, because of their high collagen content, and it causes inflammatory alterations that may lead to tearing. 7 Like in patients with primary osteoarthrosis, narrowing of the interline and sclerosis of the joint space are frequently seen. However, the radiological alterations may be much less exuberant than the clinical manifestations.
Macroscopically, patients affected by ochronosis present small particles resembling soot, encrusted in the menisci, tendons and ligaments, which confers the typical dark coloration of the joints. This could be seen in the intraoperative images of the present case (Fig. 6A-C) . The anatomopathological examination on the operative specimens confirmed the diagnosis.
There is no specific medical treatment for alkaptonuria and therefore the therapeutic approach is symptomatic. In   Fig. 3 -Cemented total hip arthroplasty performed five years before the present case. severe cases of osteoarthrosis, total arthroplasty is the preferred treatment. 7, 8 Few studies have reported the mechanical differences that may occur in the bone and soft tissues of patients who undergo arthroplasty, or the complications during the operation or postoperative follow-up.
In patients undergoing total knee arthroplasty, Spencer et al. 12 were faced with intraoperative difficulties in displacing the patella, because the quadriceps and patellar tendons were extremely hard. Although we did not have this difficulty, we observed during the operation that both the hips presented an unusually hard consistency.
In the same study, no complications relating to implant failure were detected in patients with ochronosis who underwent total arthroplasty on different joints, with 12 years of follow-up. Other studies have presented results compatible with performing arthroplasty in patients with primary osteoarthrosis. [13] [14] [15] Early treatment for alkaptonuria may be a challenge, given that the approach is symptomatic.
Cases of ochronotic arthrosis that are more advanced require surgical treatment.
As already reported total knee arthroplasty presents good results in patients with gonarthrosis secondary to this rare pathological condition.
